RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 64 filers reported holding RA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $32,000 | 0.0% | 1,073 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $32,000 | -11.1% | 1,073 | -46.5% | 0.00% | 0.0% |
| Q1 2019 | $36,000 | 0.0% | 2,004 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $36,000 | -5.3% | 2,004 | -5.4% | 0.00% | 0.0% |
| Q3 2018 | $38,000 | +72.7% | 2,119 | -2.5% | 0.00% | 0.0% |
| Q2 2018 | $22,000 | +83.3% | 2,173 | -0.7% | 0.00% | – |
| Q1 2018 | $12,000 | +100.0% | 2,189 | +210.1% | 0.00% | – |
| Q4 2017 | $6,000 | -71.4% | 706 | +53.5% | 0.00% | -100.0% |
| Q3 2017 | $21,000 | -32.3% | 460 | -71.8% | 0.00% | -75.0% |
| Q2 2017 | $31,000 | +933.3% | 1,633 | +920.6% | 0.00% | – |
| Q1 2017 | $3,000 | – | 160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,138,797 | $294,724,000 | 15.40% |
| RA Capital Management | 4,858,260 | $233,245,000 | 7.37% |
| HAVENS ADVISORS LLC | 143,266 | $6,878,000 | 6.70% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 609,614 | $29,267,000 | 6.40% |
| OMNI PARTNERS LLP | 1,052,744 | $50,542,000 | 4.45% |
| HBK INVESTMENTS L P | 2,004,042 | $96,214,000 | 4.03% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,005,600 | $96,289,000 | 3.83% |
| Versor Investments LP | 1,108,845 | $53,236,000 | 3.53% |
| OXFORD ASSET MANAGEMENT LLP | 461,016 | $22,133,000 | 3.12% |
| HighVista Strategies LLC | 63,222 | $3,035,000 | 2.81% |